nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical University10.36485/1561-6274-2024-28-2-31-36OZGMRHnefr-2313Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESОценка качества жизни больных, страдающих хронической болезнью почек, с учетом клинической вариабельности болезниAssessment of the quality of life of patients suffering from chronic kidney disease depending on the clinical variability of the diseasehttps://orcid.org/0000-0001-5789-9633РаимкуловаН. Р.RaimkulovaN. R.

Доц. Раимкулова Нарина Робертовна, д-р мед. наук

100140, г. Ташкент, ул. Богишамол, д. 223, д. 54

Associate Professor Raimkulova Narina Robertovna, MD, PhD, DMedSci

100140, Tashkent city, st. Bogishamol, House 54

robertovnanarina@gmail.comhttps://orcid.org/0000-0002-2832-4256КадироваГ. Г.KadirovaG. G.

Доц. Кадирова Гульчехра Ганиевна, канд. мед. наук

100140, г. Ташкент, ул. Богишамол, д. 223, д. 54

Associate Professor Kadirova Gulchekhra Ganievna, MD, PhD

100140, Tashkent city, st. Bogishamol, House 54

kadirovagulchehra26@gmail.comhttps://orcid.org/0000-0003-2320-0665УсмановаУ. Ш.UsmanovaU. Sh.

Доц. Усманова Умида Шухратовна, канд. мед. наук

100140, г. Ташкент, ул. Богишамол, д. 223, д. 54

Associate Professor Usmanova Umida Shukhratovna, MD, PhD

100140, Tashkent city, st. Bogishamol, House 54

umka_u@inbox.ruТашкентский педиатрический медицинский институтУзбекистанTashkent Pediatric medical instituteUzbekistan2024120720242823136Copyright © Раимкулова Н.Р., Кадирова Г.Г., Усманова У.Ш., 20242024Раимкулова Н.Р., Кадирова Г.Г., Усманова У.Ш.Raimkulova N.R., Kadirova G.G., Usmanova U.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/2313

В этой статье подробно описаны: особенности клинического течения заболевания, оценка качества жизни, диагностические критерии и современная классификация хронической болезни почек. Выявлен различный патогенез хронической болезни почек с учетом соответствия стадий хронической болезни почек кодировке по МКБ-10. В статье также подробно описаны современные методы антигипертензивной терапии у пациентов с хронической болезнью почек с учетом последних клинических рекомендаций. Описаны различные современные исследования оценки качества жизни пациентов с использованием опросника SF-36, который включает в себя 8 шкал, а именно: физическое функционирование (PF), ролевое функционирование, обусловленное физическим состоянием (RFPC), интенсивность боли (PI), общее состояние здоровья (GHS), жизнедеятельность (VA), социальное функционирование (SF), ролевое функционирование, обусловленное эмоциональным состоянием (RFES) и психическим здоровьем (MH). 

This article describes in detail: features of the clinical course of the disease, assessment of quality of life, diagnostic criteria and modern classification of chronic kidney disease. Various pathogenesis of chronic kidney disease is revealed, taking into account the correspondence of the stages of chronic kidney disease to the ICD-10 coding. The article also details the modern methods of antihypertensive therapy in patients with chronic kidney disease, taking into account the latest clinical recommendations. Various modern studies of assessing the quality of life of patients using the SF-36 questionnaire are described, which includes 8 scales, namely: physical functioning (PF), role functioning due to physical condition (RFPC), pain intensity (PI), general health status (GHS), vital activity (VA), social functioning (SF), role functioning due to emotional state (RFES) and mental health (MH).

хроническая болезнь почеккачество жизниартериальная гипертензияchronic kidney diseasequality of lifearterial hypertensionReferencesMoiseev VC, Mukhin NA, Smirnov AV et al. Cardiovascular risk and chronic kidney disease: cardio-nephroprotection strategies. Russian Journal of Cardiology 2014;(8):7–37. (In Russ.) https://doi.org/10.15829/1560-4071-2014-8-7-37Moiseev VC, Mukhin NA, Smirnov AV et al. Cardiovascular risk and chronic kidney disease: cardio-nephroprotection strategies. Russian Journal of Cardiology 2014;(8):7–37. (In Russ.) https://doi.org/10.15829/1560-4071-2014-8-7-37Living with chronic kidney disease. Interviews with the patient. Saint Petersburg, 2013Living with chronic kidney disease. Interviews with the patient. Saint Petersburg, 2013Daminov BT, Abdullaev ShS, Egamberdieva DA. Cardiac remodeling in patients with chronic kidney disease of various etiologies. Буковинський медичний вісник 2013;17(4):54–59Daminov BT, Abdullaev ShS, Egamberdieva DA. Cardiac remodeling in patients with chronic kidney disease of various etiologies. Буковинський медичний вісник 2013;17(4):54–59Абдуллаев ШС, Шарапов ОН, Асомов МИ. Сердечнососудистое ремоделирование у больных с различными формами нефропатии в стадии хронической почечной недостаточности. Молодой ученый 2017;138(4):225–229Abdullayev ShS, Sharapov ON, Asomov MI. Cardiovascular remodelling in the patients with different forms of nephropathy on the stage of chronic kidney failure. Young scientist 2017;138(4): 225–229 (In Russ.)Daminov BT, Abdullaev ShS, Sharapov ON. Characteristics of prognostic risk factors for the development of left ventricular hypertrophy in patients with chronic kidney disease of diabetic etiology. Proceedings of the IX International Scientific and Practical Conference "Modern Science: Development Trends". Krasnodar, 2015;136–142Daminov BT, Abdullaev ShS, Sharapov ON. Characteristics of prognostic risk factors for the development of left ventricular hypertrophy in patients with chronic kidney disease of diabetic etiology. Proceedings of the IX International Scientific and Practical Conference "Modern Science: Development Trends". Krasnodar, 2015;136–142Daminov BT. et al. Prognostic risk factors for the development of left ventricular hypertrophy in patients with chronic kidney disease. Proceedings of the IX International Scientific and Practical Conference "Modern Science: Development Trends". Krasnodar, 2015;143–149Daminov BT. et al. Prognostic risk factors for the development of left ventricular hypertrophy in patients with chronic kidney disease. Proceedings of the IX International Scientific and Practical Conference "Modern Science: Development Trends". Krasnodar, 2015;143–149Даминов БТ, Мирзаева БМ. Сосудистое ремоделирование у больных, находящихся на программном гемодиализе. Нефрология 2019; 23 (приложение 1):115. doi: 10.36485/15616274-2019-23-5-100-129Daminov BT, Mirzaevа BM. Vascular remodeling in program hemodialysis patients. Nephrology (Saint-Petersburg) 2019; 23 (supplement 1): 115 (In Russ.). doi: 10.36485/1561-6274-2019-23-5-100-129Rasulev YE, Pirmanov ShV. Aspects of the development of chronic renal failure. Modern scientific research and development. 2017;(2):181–182Rasulev YE, Pirmanov ShV. Aspects of the development of chronic renal failure. Modern scientific research and development. 2017;(2):181–182Раимкулова НР. Липидный и белковый спектр крови у больных хроническим гломерулонефритом с нефротическим синдромом. Молодой ученый 2016;115(11):1169–1171Raimkulova NR. Lipid and protein spectrum of blood in patients with chronic glomerulonephritis with nephrotic syndrome. Young scientist 2016;115(11):1169–1171Раимкулова НР, Курбонова МБ, Ортикбоев ФД, Усмонбекова ГУ. Нефропротективное действие статинов у больных с хроническим гломерулонефритом. Молодой ученый 2017;142(8):131–133Raimkulova NR, Kurbanova MB, Ortikboev FD, Usmonbekova GU. Nephroprotective effect of statins in patients with chronic glomerulonephritis. Young scientist 2017;142(8):131–133Sabirov MA. Features of the circadian rhythm of blood pressure in patients with chronic kidney disease. Modern science: development trends 2016;16:134–141Sabirov MA. Features of the circadian rhythm of blood pressure in patients with chronic kidney disease. Modern science: development trends 2016;16:134–141Khakimov DP, Ortikboev JO, Ortikboeva ShO. Evaluation of the emotional state of children on chronic program dialysis. Priority scientific directions: from theory to practice. Kidney Disease 2016;(16):134–141Khakimov DP, Ortikboev JO, Ortikboeva ShO. Evaluation of the emotional state of children on chronic program dialysis. Priority scientific directions: from theory to practice. Kidney Disease 2016;(16):134–141Egamberdieva DA, Saipova DS. Relationship between renal function and physical activity in patients with pre-dialysis chronic kidney disease. Bulletin of TTA 2019; (3):141–144Egamberdieva DA, Saipova DS. Relationship between renal function and physical activity in patients with pre-dialysis chronic kidney disease. Bulletin of TTA 2019; (3):141–144Egamberdieva DA, Saipova DS. The role of correction of physical activity of patients in the program of rehabilitation of patients with CKD. Therapeutic Bulletin of Uzbekistan 2019; (1):108–111Egamberdieva DA, Saipova DS. The role of correction of physical activity of patients in the program of rehabilitation of patients with CKD. Therapeutic Bulletin of Uzbekistan 2019; (1):108–111Egamberdieva DA, Daminov BT, Sabirzhanova ZT. Chronic kidney disease (issues of pathogenesis and diagnosis). Publishing house “Ijod-Print”, Tashkent, 2018Egamberdieva DA, Daminov BT, Sabirzhanova ZT. Chronic kidney disease (issues of pathogenesis and diagnosis). Publishing house “Ijod-Print”, Tashkent, 2018Egamberdieva DA. Treatment of chronic kidney disease. Publishing house “Ijod-Print”, Tashkent, 2018Egamberdieva DA. Treatment of chronic kidney disease. Publishing house “Ijod-Print”, Tashkent, 2018Egamberdieva DA. Diagnosis of Chronic Kidney Disease. Ijod-Print Publishing House, Tashkent, 2018Egamberdieva DA. Diagnosis of Chronic Kidney Disease. Ijod-Print Publishing House, Tashkent, 2018Egamberdieva DA, Ruzmetova IA, Rasulev EE. Risk factors and progression of chronic kidney disease. Therapeutic Bulletin of Uzbekistan 2017;(4):91–96Egamberdieva DA, Ruzmetova IA, Rasulev EE. Risk factors and progression of chronic kidney disease. Therapeutic Bulletin of Uzbekistan 2017;(4):91–96Egamberdieva DA, Ruzmetova IA. Functional disorders of kidney function in patients with chronic heart failure. Therapeutic Bulletin of Uzbekistan 2017;(4):114–116Egamberdieva DA, Ruzmetova IA. Functional disorders of kidney function in patients with chronic heart failure. Therapeutic Bulletin of Uzbekistan 2017;(4):114–116Raimkulova NR. Lipid metabolism disorders in chronic glomerulonephritis. Statin therapy. Print Publishing House “Ishonch nashr savdo”, Tashkent, 2017, 115Raimkulova NR. Lipid metabolism disorders in chronic glomerulonephritis. Statin therapy. Print Publishing House “Ishonch nashr savdo”, Tashkent, 2017, 115Olimkhonova KN, Egamberidieva DA. Chronic kidney disease: pathophysiological role of intestinal dysbiosis and renoprotective efficacy of interventions for its modulation. Therapeutic Bulletin of Uzbekistan 2019;(4):138–142Olimkhonova KN, Egamberidieva DA. Chronic kidney disease: pathophysiological role of intestinal dysbiosis and renoprotective efficacy of interventions for its modulation. Therapeutic Bulletin of Uzbekistan 2019;(4):138–142Muminov DK. Functional changes of kidneys in patients with pneumonia. European journal of pharmaceutical and medical research 2020;7(2):35–37Muminov DK. Functional changes of kidneys in patients with pneumonia. European journal of pharmaceutical and medical research 2020;7(2):35–37Khalmukhamedov JA, On the issue of an objective assessment of acute pain. Bulletin of Emergency Medicine 2019; 12(2):57–65Khalmukhamedov JA, On the issue of an objective assessment of acute pain. Bulletin of Emergency Medicine 2019; 12(2):57–65Raimkulova NR, Kadirova GG, Kidney damage in metabolic syndrome. Therapeutic Bulletin of Uzbekistan 2019;(4):96–103Raimkulova NR, Kadirova GG, Kidney damage in metabolic syndrome. Therapeutic Bulletin of Uzbekistan 2019;(4):96–103Kamilova UK, Masharipova DR. The study of indicators of kidney dysfunction in patients with CHF. Therapeutic Bulletin of Uzbekistan 2019;(4):34–37Kamilova UK, Masharipova DR. The study of indicators of kidney dysfunction in patients with CHF. Therapeutic Bulletin of Uzbekistan 2019;(4):34–37K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification / National Kidney Foundation. Am J Kidney Dis 2002;39(2, Suppl 1):1–266K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification / National Kidney Foundation. Am J Kidney Dis 2002;39(2, Suppl 1):1–266Wachtell K, Olsen MH, Dahlöf B et al. Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. J Hypertens 2002 Mar;20(3):405–412. doi: 10.1097/00004872-200203000-00015Wachtell K, Olsen MH, Dahlöf B et al. Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. J Hypertens 2002 Mar;20(3):405–412. doi: 10.1097/00004872-200203000-00015Aladinsky VA, Nikiforov NG, Temchenko AV et al. Molecular – cellular changes in atherosclerosis. Clinical medicine 2015; (6):14–18Aladinsky VA, Nikiforov NG, Temchenko AV et al. Molecular – cellular changes in atherosclerosis. Clinical medicine 2015; (6):14–18Atakhodjaeva GA. Quality of life and functional state of the kidneys in patients with chronic heart failure and metabolic syndrome. Therapeutic Bulletin of Uzbekistan 2015; (2): 202–207Atakhodjaeva GA. Quality of life and functional state of the kidneys in patients with chronic heart failure and metabolic syndrome. Therapeutic Bulletin of Uzbekistan 2015; (2): 202–207Lipska KJ. Metformin Use in Patients With Historical Contraindications. Annals of Internal Medicine 2017;166 (3):225Lipska KJ. Metformin Use in Patients With Historical Contraindications. Annals of Internal Medicine 2017;166 (3):225Sorino C, Scichilone N, Pedone C, Negri S, Visca D, Spanevello A. When kidneys and lungs suffer together. J Nephrol 2019 Oct;32(5):699–707. doi: 10.1007/s40620-018-00563-1Sorino C, Scichilone N, Pedone C, Negri S, Visca D, Spanevello A. When kidneys and lungs suffer together. J Nephrol 2019 Oct;32(5):699–707. doi: 10.1007/s40620-018-00563-1Muminov DK. Sciences clinical features of pneumonia on the background with chronic kidney disease. International Journal of Pulmonary and Respiratory Sciences. Delhi, India 2019;1(1): 10–12Muminov DK. Sciences clinical features of pneumonia on the background with chronic kidney disease. International Journal of Pulmonary and Respiratory Sciences. Delhi, India 2019;1(1): 10–12Jager KJ, Kovesdy C, Langham R et al. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Kidney Int 2019 Nov;96(5):1048–1050. doi: 10.1016/j.kint.2019.07.012Jager KJ, Kovesdy C, Langham R et al. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Kidney Int 2019 Nov;96(5):1048–1050. doi: 10.1016/j.kint.2019.07.012Levin A, Tonelli M, Bonventre J et al. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet 2017 Oct 21;390(10105):1888–1917. doi: 10.1016/S0140-6736(17)30788-2Levin A, Tonelli M, Bonventre J et al. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet 2017 Oct 21;390(10105):1888–1917. doi: 10.1016/S0140-6736(17)30788-2Crews DC, Bello AK, Saadi G. World Kidney Day Steering Committee. Burden, access, and disparities in kidney disease. Kidney Int 2019 Feb;95(2):242–248. doi: 10.1016/j.kint.2018.11.007Crews DC, Bello AK, Saadi G. World Kidney Day Steering Committee. Burden, access, and disparities in kidney disease. Kidney Int 2019 Feb;95(2):242–248. doi: 10.1016/j.kint.2018.11.007Hill NR, Fatoba ST, Oke JL et al. Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis. PLoS One 2016 Jul 6;11(7):e0158765. doi: 10.1371/journal.pone.0158765Hill NR, Fatoba ST, Oke JL et al. Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis. PLoS One 2016 Jul 6;11(7):e0158765. doi: 10.1371/journal.pone.0158765Xie Y, Bowe B, Mokdad AH et al. Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int 2018 Sep;94(3):567–581. doi: 10.1016/j.kint.2018.04.011Xie Y, Bowe B, Mokdad AH et al. Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int 2018 Sep;94(3):567–581. doi: 10.1016/j.kint.2018.04.011

The authors declare that there are no conflicts of interest present.